The National Institute for Communicable Diseases says it expects that the current Covid-19 vaccines will continue to protect individuals from severe disease and death after a new mutation of the virus was detected.

Published on

31 August 2021

Researchers identified a potential SARS-CoV-2 variant of interest and published the results last week. The variant was detected through genomic surveillance of the virus during the third wave of infections and was first discovered in Gauteng and Mpumalanga in May. Senior researcher at the NICD Prof Penny Moore says currently the incidence of the variant, called C.1.2 is very low.

Merentia Van Der Vent

Merentia joined the media world in 1996 and in 2001, she took her first steps in the broadcasting world. In her free time, she likes to go on adventures in the city. She also likes to learn new dances, not that she is any good at that.

Latest articles

NICD keeping a close eye on new Covid-19 variant – C.1.2 – Delta remains dominant

South Africa has confirmed another 5 644 new cases of the coronavirus, over the latest 24-hour monitoring period.

The National Institute for Communicable Diseases says it expects that the current Covid-19 vaccines will continue to protect individuals from severe disease and death after a new mutation of the virus was detected.

Latest articles

Betway SA20: MI Cape Town off to a good start

Blitzboks Brace for Tough SVNS Pool in Perth

NICD: No need to panic over HMPV virus spreading in China

Are you ready to play again? Because the game has begun

Are you ready to play again? Because the game has begun

The City says the ‘Project Blue’ report falsely claims water quality data is from accredited labs

A bleak Christmas lies ahead for many left destitute after several fires

Click here for T&cs